Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

607 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Active, not recruiting

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

NCT06092879

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Saint Priest Jarez, Pays de la Loire Region, France
  • Novartis Investigative Site Aix-en-Provence, France
View all 52 locations
View Trial Details
Active, not recruiting

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

NCT02091245

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia (CML) in Blast Crisis, +26 more
Locations
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population

NCT04626024

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +13 more
Locations
  • Baylor College of Medicine- McNair Campus Houston, Texas, United States
  • Ben Taub General Hospital Houston, Texas, United States
  • CHI St. Luke's Health Baylor College of Medicine Medical Center Houston, Texas, United States
  • Harris Health System- Smith Clinic Houston, Texas, United States
View Trial Details
Active, not recruiting

Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors

NCT03610971

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +13 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory -Winship Cancer Institute Atlanta, Georgia, United States
  • Memorial Sloan Kettering - Bergen Montvale, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, not recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details

Related conditions